Product
HERCESSI™ (trastuzumab-strf)
PHARMACEUTICAL
byAccord BioPharma
United States (US)
ABOUT THE PRODUCT
HERCESSI™ is a trastuzumab-strf biosimilar, now preferred under Express Scripts and Cigna Healthcare formularies, offering patients a reliable and affordable treatment option for HER2-positive cancers.
Information is owner-confirmed
Last updated 1 month ago
Price range